Europe Medical Aesthetic Devices Market Growth, Size, Trends, Demand, Share and Future Outlook

Europe Medical Aesthetic Devices Market Size- By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Europe Medical Aesthetic Devices Market Size- By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Apr 2024 Report ID: MEDE2423 Pages: 1 - 159 Formats*:     
Category : Medical Devices
Europe Medical Aesthetic Devices Market Introduction and Overview

According to SPER Market Research, the Europe Medical Aesthetic Devices Market is estimated to reach USD XX Billion by 2033 with a CAGR of 11.67%.

The report includes an in-depth analysis of the Europe Medical Aesthetic Devices Market, including market size and trends, product mix, applications, and supplier analysis. Medical aesthetic devices are specialised equipment and instruments used in cosmetic operations to enhance people's aesthetic look. These gadgets are intended to be less invasive and provide non-surgical alternatives to traditional cosmetic surgery. Medical aesthetic devices use technologies including laser, radiofrequency, ultrasound, and light therapy to target particular parts of the body and address a variety of aesthetic disorders. These devices are used for a variety of procedures, including skin rejuvenation, hair removal, body sculpting, and facial augmentation.

  • October 2022: Evolus, Inc. entered the British market in, beginning commercial operations and shipping Nuceiva (botulinum toxin type A). This move sought to increase the company's footprint in the European market while also giving patients with a new alternative for aesthetic treatments.
  • October 2022: GC Aesthetics got CE mark clearance for their new micro-textured anatomical breast implant, the LUNA xt, under the new European Medical Device Regulation (MDR). This certification allows the company to market and distribute the implant within the European Union, giving women a new alternative for breast augmentation surgery. The novel implant has a unique form and texture that seeks to improve patient outcomes while lowering the risk of problems. 
Europe Medical Aesthetic Devices Market
Market Opportunities and Challenges
The Europe medical aesthetic devices market presents a range of opportunities amid certain challenges. Opportunities include the increasing demand for minimally invasive procedures, driven by a growing consumer preference for non-surgical aesthetic treatments. Advancements in technology, such as laser therapy and energy-based devices, offer innovative solutions for various aesthetic concerns, contributing to market growth. Additionally, the rising adoption of aesthetic procedures among the aging population and younger demographics seeking cosmetic enhancements fuels market expansion. 

However, challenges persist, including stringent regulatory requirements and compliance standards that may hinder market entry for manufacturers. Economic uncertainties and healthcare budget constraints in some European countries could also impede market growth. Furthermore, competition among market players and the need for continuous innovation pose challenges for sustaining market leadership and differentiation. Overall, navigating these opportunities and challenges requires strategic investments in research and development, regulatory compliance, and market expansion initiatives.

Europe Medical Aesthetic Devices Market


Market Competitive Landscape
The European market for medical aesthetic devices is moderately fragmented, with both small and major manufacturers present. To preserve their market position, these corporations use a variety of critical techniques, including partnerships, product approvals, and collaborations. The major key players in the Europe Medical Aesthetic Devices Market are: Abbvie Inc (Allergan Inc.), Aerolase Corporation, Bausch Health Companies Inc. (Solta Medical Inc.), Cynosure, Cutera Inc., Galderma SA, Human Med AG, Johnson & Johnson (Mentor Worldwide), Lumenis Inc., Merz Pharma GmbH & Co. KGaA, Sciton Inc., Sisram Medical (Alma Lasers), Syneron Medical Ltd, Others.

Scope of the Report:
 Report Metric Details
 Market size available for years 2020-2033
 Base year considered 2023
 Forecast period 2024-2033
 Segments coveredBy Type, By Application, By End User
 Regions covered
Belgium, France, Germany, Italy, Netherlands, Russia, Spain, Switzerland, The U.K., Turkey, Rest of Europe
 Companies CoveredAbbvie Inc (Allergan Inc.), Aerolase Corporation, Bausch Health Companies Inc. (Solta Medical Inc.), Cynosure, Cutera Inc., Galderma SA, Human Med AG, Johnson & Johnson (Mentor Worldwide), Lumenis Inc., Merz Pharma GmbH & Co. KGaA, Sciton Inc., Sisram Medical (Alma Lasers), Syneron Medical Ltd, Others.
COVID-19 Impact on Europe Medical Aesthetic Devices Market
The COVID-19 epidemic had a huge impact on Europe's medical aesthetic device business. The temporary closure of aesthetic clinics and the halting of non-essential services during lockdowns led to a market drop. However, as restrictions were lifted and clinics reopened, the demand for aesthetic procedures began to rebound. The pandemic underlined the need of non-surgical therapies, as patients sought minimally invasive procedures with shorter recovery times. Virtual consultations and telemedicine solutions gained popularity, allowing for distant examinations and consultations. To protect the well-being of patients and personnel, the market has seen an increase in attention on safety measures and infection control methods.

Key Target Audience:
  • Clinics and Medical Spas
  • Hospitals and Surgical Centers
  • Dermatologists and Plastic Surgeons
  • Aesthetic Practitioners
  • Medical Device Manufacturers
  • Distributors and Suppliers
  • Healthcare Professionals
  • Others
Our in-depth analysis of the Europe Medical Aesthetic Devices Market includes the following segments:
By Type:
  • Energy-Based Aesthetic Devices
  • Non-Energy-Based Aesthetic Devices
  • By Application:
  • Body Contouring and Cellulite Reduction
  • Breast Augmentation
  • Hair Removal
  • Skin Resurfacing and Tightening
  • Other Applications
  • By End User:
  • Clinics
  • Hospitals
  • Other End-Users
  • Key Topics Covered in the Report:
    • Europe Medical Aesthetic Devices Market Size (FY’2024-FY’2033)
    • Overview of Europe Medical Aesthetic Devices Market
    • Segmentation of Europe Medical Aesthetic Devices Market By Type (Energy-Based Aesthetic Devices, Non-Energy-Based Aesthetic Devices)
    • Segmentation of Europe Medical Aesthetic Devices Market By Application (Body Contouring and Cellulite Reduction, Breast Augmentation, Hair Removal, Skin Resurfacing and Tightening, Other Applications)
    • Segmentation of Europe Medical Aesthetic Devices Market By End User (Clinics, Hospitals, Other End-Users Clinics, Hospitals, Other End-Users)
    • Statistical Snap of Europe Medical Aesthetic Devices Market 
    • Expansion Analysis of Europe Medical Aesthetic Devices Market 
    • Problems and Obstacles in Europe Medical Aesthetic Devices Market
    • Competitive Landscape in the Europe Medical Aesthetic Devices Market
    • Impact of COVID-19 and Demonetization on Europe Medical Aesthetic Devices Market 
    • Details on Current Investment in Europe Medical Aesthetic Devices Market
    • Competitive Analysis of Europe Medical Aesthetic Devices Market 
    • Prominent Players in the Europe Medical Aesthetic Devices Market 
    • SWOT Analysis of Europe Medical Aesthetic Devices Market 
    • Europe Medical Aesthetic Devices Market Future Outlook and Projections (FY’2024-FY’2033)
    • Recommendations from Analyst

    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Europe Medical Aesthetic Devices Market 

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Europe Medical Aesthetic Devices Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Medical Aesthetic Devices Market 

    7. Europe Medical Aesthetic Devices Market, By Type (USD Million) 2020-2033
    7.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Type, 2020-2026
    7.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Type, 2027-2033
    7.3. Energy-Based Aesthetic Devices 
    7.3.1. Laser-based Aesthetic Devices
    7.3.2. Light-based Aesthetic Devices
    7.3.3. Radiofrequency (RF) Based Aesthetic Devices
    7.3.4. Ultrasound Aesthetic Devices 
    7.4. Non-Energy-Based Aesthetic Devices 
    7.4.1. Botulinum Toxin
    7.4.2. Chemical Peels
    7.4.3. Dermal Fillers and Aesthetic Threads
    7.4.4. Implants
    7.4.5. Microdermabrasion
    7.4.6. Other Aesthetic Devices 

    8. Europe Medical Aesthetic Devices Market, By Application (USD Million) 2020-2033
    8.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Application, 2020-2026
    8.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Application, 2027-2033
    8.3. Body Contouring and Cellulite Reduction
    8.4. Breast Augmentation
    8.5. Hair Removal
    8.6. Skin Resurfacing and Tightening
    8.7. Other Applications 

    9. Europe Medical Aesthetic Devices Market, By End User (USD Million) 2020-2033
    9.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By End User, 2020-2026
    9.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By End User, 2027-2033
    9.3. Clinics
    9.4. Hospitals
    9.5. Other End-Users 

    10. Europe Medical Aesthetic Devices Market Forecast, 2020-2033 (USD Million)
    10.1. Europe Medical Aesthetic Devices Market Size and Market Share

    11. Europe Medical Aesthetic Devices Market, By Region, 2020-2033 (USD Million)
    11.1. Europe Medical Aesthetic Devices Market Size and Market Share By Region (2020-2026)
    11.2. Europe Medical Aesthetic Devices Market Size and Market Share By Region (2027-2033)
    11.3. Belgium
    11.4. France
    11.5. Germany
    11.6. Italy
    11.7. Netherlands
    11.8. Russia
    11.9. Spain
    11.10. Switzerland
    11.11. Turkey
    11.12. U.K.
    11.13. Rest of Europe in Europe

    12. Company Profile
    12.1. Abbvie Inc (Allergan Inc)
    12.1.1. Company details
    12.1.2. Financial outlook
    12.1.3. Product summary 
    12.1.4. Recent developments
    12.2. Aerolase Corporation
    12.2.1. Company details
    12.2.2. Financial outlook
    12.2.3. Product summary 
    12.2.4. Recent developments
    12.3. Bausch Health Companies Inc. (Solta Medical Inc.)
    12.3.1. Company details
    12.3.2. Financial outlook
    12.3.3. Product summary 
    12.3.4. Recent developments
    12.4. Cynosure
    12.4.1. Company details
    12.4.2. Financial outlook
    12.4.3. Product summary 
    12.4.4. Recent developments
    12.5. Cutera Inc
    12.5.1. Company details
    12.5.2. Financial outlook
    12.5.3. Product summary 
    12.5.4. Recent developments
    12.6. Galderma SA
    12.6.1. Company details
    12.6.2. Financial outlook
    12.6.3. Product summary 
    12.6.4. Recent developments
    12.7. Human Med AG
    12.7.1. Company details
    12.7.2. Financial outlook
    12.7.3. Product summary 
    12.7.4. Recent developments
    12.8. Johnson & Johnson (Mentor Worldwide)
    12.8.1. Company details
    12.8.2. Financial outlook
    12.8.3. Product summary 
    12.8.4. Recent developments
    12.9. Lumenis Inc
    12.9.1. Company details
    12.9.2. Financial outlook
    12.9.3. Product summary 
    12.9.4. Recent developments
    12.10. Merz Pharma GmbH & Co. KGaA
    12.10.1. Company details
    12.10.2. Financial outlook
    12.10.3. Product summary 
    12.10.4. Recent developments
    12.11. Sciton Inc
    12.11.1. Company details
    12.11.2. Financial outlook
    12.11.3. Product summary 
    12.11.4. Recent developments
    12.12. Sisram Medical (Alma Lasers)
    12.12.1. Company details
    12.12.2. Financial outlook
    12.12.3. Product summary 
    12.12.4. Recent developments
    12.13. Syneron Medical Ltd
    12.13.1. Company details
    12.13.2. Financial outlook
    12.13.3. Product summary 
    12.13.4. Recent developments
    12.14. Others 
     
    13. List of Abbreviations

    14. Reference Links

    15. Conclusion

    16. Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Medical aesthetic devices are specialised equipment and instruments used in cosmetic operations to enhance people's aesthetic look.
    Europe Medical Aesthetic Devices Market is projected to reach USD XX billion by 2033, growing at a CAGR of 11.67% during the forecast period.
    Europe Medical Aesthetic Devices Market grew in Market size from 2022. The Market is expected to reach USD XX billion by 2033, at a CAGR of 11.67% during the forecast period.
    Europe Medical Aesthetic Devices Market CAGR of 11.67% during the forecast period.
    Europe Medical Aesthetic Devices Market size is USD XX billion from 2024 to 2033.
    Europe Medical Aesthetic Devices Market Segment is covered By Type, By Application, By End User.
    The Europe is anticipated to have the highest Market share in the Europe Medical Aesthetic Devices Market.
    The key players in the Market include Companies Covered Abbvie Inc (Allergan Inc.), Aerolase Corporation, Bausch Health Companies Inc. (Solta Medical Inc.), Cynosure, Cutera Inc., Galderma SA, Human Med AG, Sisram Medical (Alma Lasers), Syneron Medical Ltd, Others.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-McKinsey
    SPER-Bain
    SPER-Max-Healthcare
    SPER-DHL
    SPER-SIEMENS
    SPER-IQVIA
    SPER-Pfizer
    SPER-LOREAL
    SPER-Kankar IMRB
    SPER-ITA
    SPER-PWC
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-IPSOS
    SPER-Heineken

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650